Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol

NCT05657704 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Post-surgical Pain
Pain, Acute
Postoperative Pain

Interventions

DRUG: The patients in experimental group will be genotyped before surgery and treatment will be prescribed according to the CYP2D6 phenotype

Sponsor

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]